Allopurinol EP Impurity B
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

22407-20-1Allopurinol EP Impurity B

● In Stock

Catalogue No.:VL1430002
CAS No.:22407-20-1
Mol. Formula:C5H6N4O2
Mol. Weight:154.13 g/mol

Additional information on CAS 22407-20-1

Parent drug

Allopurinol

IUPAC Name

5-(formylamino)-1H-pyrazole-4-carboxamide

Pharmacopoeial Synonyms

Allopurinol Related Compound B

Other Synonyms

3-Formamidopyrazole-4-carboxamide ;1H-Pyrazole-4-carboxamide, 3-(formylamino)

Smiles

O=C(C1=C(NC=O)NN=C1)N

InChI

InChI=1S/C5H6N4O2/c6-4(11)3-1-8-9-5(3)7-2-10/h1-2H,(H2,6,11)(H2,7,8,9,10)

Description

Allopurinol EP Impurity B also known in pharmacopoeias as Allopurinol Related Compound B is a thoroughly characterized reference standard. It meets strict regulatory standards including those set by USP EMA JP and BP. This product is crucial for use in Abbreviated New Drug Applications (ANDA) New Drug Applications (NDA) and the commercial production of Acyclovir . Additionally it comes with a detailed Structure Elucidation Report (SER) ensuring its precision and dependability for a variety of analytical uses. Allopurinol EP Impurity B (CAS No: 22407-20-1) or Allopurinol Related Compound B/5-(formylamino)-1H-pyrazole-4-carboxamide is an impurity formed during the synthesis of Allopurinol that is an oxypurine base used as a first-choice drug in the management of primary and secondary hyperuricemia.

References

Murrell, G. A. C., and W. G. Rapeport. “Clinical Pharmacokinetics of Allopurinol.” Clinical Pharmacokinetics, vol. 11, no. 5, 1986, pp. 343–53, https://doi.org/10.2165/00003088-198611050-00001. Osabe, Makoto, et al. “In Silico Analysis of Interactions between HLA-B*58:01 and Allopurinol-Related Compounds.” Chem-Bio Informatics Journal, vol. 16, no. 0, 2016, pp. 1–4, https://doi.org/10.1273/cbij.16.1. ‌

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url